[VIRTUAL] Efficacy and safety of bevacizumab biosimilar FKB238 versus originator bevacizumab: Results from a phase III trial in patients with non-squamous non-small cell lung cancer (NS-NSCLC).

paclitaxel - Generic mfg.

Equidacent (bevacizumab biosimilar) - Fujifilm Kyowa Kirin Biologics, AstraZeneca, Centus Biotherap

carboplatin - Generic mfg.

https://meetinglibrary.asco.org/record/185698

Konstantinos N. Syrigos; Dongyue Fu; Stephanie Jones; Zahid Bashir; on behalf of the FKB238-002 Investigators

Apr 29, 2020